Yüklüyor......
Pathway inhibition: emerging molecular targets for treating glioblastoma
Insights into the molecular pathogenesis of glioblastoma have not yet resulted in relevant clinical improvement. With standard therapy, which consists of surgical resection with concomitant temozolomide in addition to radiotherapy followed by adjuvant temozolomide, the median duration of survival is...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3107100/ https://ncbi.nlm.nih.gov/pubmed/21636705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor039 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|